MedTech I.Q.

The Cutting Edge of Medical Technology Content, Community & Collaboration

GMP and Regulatory Expectations for Early IND Products - 2-day In-person Seminar

Event Details

GMP and Regulatory Expectations for Early IND Products - 2-day In-person Seminar

Time: May 21, 2015 at 9am to May 22, 2015 at 6pm
Location: Boston, MA
Street: Boston, MA
City/Town: Boston
Website or Map: https://www.globalcompliancep…
Phone: 18004479407
Event Type: food, fda, medical, device, defence, and, navy, aerospace, mining
Organized By: GlobalCompliancePanel
Latest Activity: Feb 24, 2015

Export to Outlook or iCal (.ics)

Event Description

Overview:

This course will present, in one place, the regulations and guidelines that apply to early phase products. In some cases these will not be regulations, but needs that, if met, will increase the efficiency of activities as a product proceeds through the development process. The course will present these items in the order of product development from the point of R & D activities to the completion of Phase 2 clinical trials.


Why should you attend:
Any pharmaceutical worker who must deal with products both in early and latter phases of development should attend this course in order to be aware of the regulatory requirements that will affect operations dealing with these products. The modifications to the GMPs for early phase products have modified the GMPs in such a way as to reduce requirements to allow more efficient work. At the same time some of the things that may appear to have changed, have not, and the pharmaceutical worker should be aware of this.

Speaker:

Dr. Steven Kuwahara, Ph.D. is the founder and Principal of GXP BioTechnology LLC, a consulting firm that works in the areas covered by the GLP and GMP of drugs, biologics, and nutraceuticals. Steve has over 30 years of experience in supervising quality control laboratories, including an animal testing facility, and in performing GLP and GMP audits of internal and external testing laboratories . Steve has participated in the development of drugs and biologicals through all phases of clinical research and final product production.

Price: $1,295.00

Quick Contact:

NetZealous BDA as GlobalCompliancePanel

USA Phone:1-800-447-9407
Fax: 302-288-6884
support@globalcompliancepanel.com
http://www.globalcompliancepanel.com

Comment Wall

Comment

RSVP for GMP and Regulatory Expectations for Early IND Products - 2-day In-person Seminar to add comments!

Join MedTech I.Q.

Attending (1)

© 2019   Created by CC-Conrad Clyburn-MedForeSight.   Powered by

Badges  |  Report an Issue  |  Terms of Service